Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, such as statements about demand for and customer acceptance of FARO's products, FARO's product development and product launches, FARO's growth, strategic and restructuring plans and initiatives, including but not limited to the additional restructuring charges expected to be incurred in connection with our restructuring plan and the timing and amount of cost savings and other benefits expected to be realized from the restructuring plan and other strategic initiatives, and FARO's growth potential and profitability. Statements that are not historical facts or that describe the Company's plans, objectives, projections, expectations, assumptions, strategies, or goals are forward-looking statements. In addition, words such as "is," "will" and similar expressions or discussions of FARO's plans or other intentions identify forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to various known and unknown risks, uncertainties, and other factors that may cause actual results, performances, or achievements to differ materially from future results, performances, or achievements expressed or implied by such forward-looking statements. Consequently, undue reliance should not be placed on these forward-looking statements.
Factors that could cause actual results to differ materially from what is expressed or forecasted in such forward- looking statements include, but are not limited to:
- the Company's ability to realize the intended benefits of its undertaking to transition to a company that is reorganized around functions to improve the efficiency of its sales organization and to improve operational effectiveness;
- the Company's inability to successfully execute its new strategic plan and restructuring plan, including but not limited to additional impairment charges and/or higher than expected severance costs and exit costs, and its inability to realize the expected benefits of such plans;
- the Company's potential loss of future government sales and potential impacts on customer and supplier relationships and on the Company's reputation that may result from the GSA matter;
- development by others of new or improved products, processes or technologies that make the Company's products less competitive or obsolete;
- the Company's inability to maintain its technological advantage by developing new products and enhancing its existing products;
- declines or other adverse changes, or lack of improvement, in industries that the Company serves or the domestic and international economies in the regions of the world where the Company operates and other general economic, business, and financial conditions;
- the effect of the COVID-19 pandemic, including on our business operations, as well as its impact on general economic and financial market conditions;
- the impact of fluctuations in foreign exchange rates; and
- other risks detailed in Part I, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 that was filed on February 17, 2021.
Forward-looking statements in this release represent the Company's judgment as of the date of this release. The Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law.
FARO TECHNOLOGIES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) | |||||||
| |||||||
| Three Months Ended | ||||||
(in thousands, except share and per share data) | March 31, 2021 |
| March 31, 2020 | ||||
Sales |
|
|
| ||||
Product | $ | 54,635 |
|
| $ | 56,525 |
|
Service | 21,696 |
|
| 22,990 |
| ||
Total sales | 76,331 |
|
| 79,515 |
| ||
Cost of Sales |
|
|
| ||||
Product | 24,804 |
|
| 23,066 |
| ||
Service | 11,120 |
|
| 12,576 |
| ||
Total cost of sales | 35,924 |
|
| 35,642 |
| ||
Gross Profit | 40,407 |
|
| 43,873 |
| ||
Operating Expenses |
|
|
| ||||
Selling, general and administrative | 33,348 |
|
| 36,324 |
| ||
Research and development | 11,973 |
|
| 10,415 |
| ||
Restructuring costs | 1,524 |
|
| 13,688 |
| ||
Total operating expenses | 46,845 |
|
| 60,427 |
| ||
Loss from operations | (6,438) |
|
| (16,554) |
| ||
Other (income) expense |
|
|
| ||||
Interest expense, net | 10 |
|
| 34 |
| ||
Other (income) expense, net | (1,615) |
|
| 473 |
| ||
Loss before income tax benefit | (4,833) |
|
| (17,061) |
| ||
Income tax benefit | (1,612) |
|
| (2,238) |
| ||
Net loss | $ | (3,221) |
|
| $ | (14,823) |
|
Net loss per share - Basic | $ | (0.18) |
|
| $ | (0.84) |
|
Net loss per share - Diluted | $ | (0.18) |
|
| $ | (0.84) |
|
Weighted average shares - Basic | 18,076,410 |
|
| 17,616,964 |
| ||
Weighted average shares - Diluted | 18,076,410 |
|
| 17,616,964 |
|